Harrow, Inc. Increase (Decrease) in Accounts Payable
Harrow, Inc. (HROW) reported Increase (Decrease) in Accounts Payable of $38.10 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2012-05-10
- Harrow, Inc. increase (decrease) in accounts payable for the quarter ending 2012-03-31 was $38.10K, a 56.30% decline year-over-year.
- Harrow, Inc. increase (decrease) in accounts payable for the quarter ending 2011-12-31 was $40.20K.
- Harrow, Inc. increase (decrease) in accounts payable for the quarter ending 2011-09-30 was $2.35K.
- Harrow, Inc. increase (decrease) in accounts payable for the quarter ending 2011-06-30 was $15.25K.
- Harrow, Inc. increase (decrease) in accounts payable for fiscal 2011 was $144.98K.
- Harrow, Inc. increase (decrease) in accounts payable for fiscal 2010 was -$607.38K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 155 month | Increase (Decrease) in Accounts Payable 158 month | Increase (Decrease) in Accounts Payable 161 month | Increase (Decrease) in Accounts Payable 164 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | $38.10K 10-Q · filed 2012-05-10 | $78.30K derived: sum of 2 quarters · filed 2012-05-10 | $80.65K derived: sum of 3 quarters · filed 2012-05-10 | $95.89K derived: sum of 4 quarters · filed 2012-05-10 | $346.62K 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $40.20K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $42.55K derived: sum of 2 quarters · filed 2012-02-23 | $57.80K derived: sum of 3 quarters · filed 2012-02-23 | $144.98K 10-K · filed 2012-02-23 | $308.53K 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $2.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | $17.59K derived: sum of 2 quarters · filed 2012-02-23 | $104.78K 10-Q · filed 2012-02-23 | $76.25K derived: sum of 4 quarters · filed 2012-05-10 | $268.33K 10-Q · filed 2012-02-23 | |||
| 2011-06-30 | $15.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-23 | $102.43K 10-Q · filed 2012-02-23 | $73.90K derived: sum of 3 quarters · filed 2012-05-10 | $27.56K derived: sum of 4 quarters · filed 2012-05-10 | $265.98K 10-Q · filed 2012-02-23 | |||
| 2011-03-31 | $87.18K 10-Q · filed 2012-05-10 | $58.66K derived: sum of 2 quarters · filed 2012-05-10 | $12.31K derived: sum of 3 quarters · filed 2012-05-10 | |||||
| 2010-12-31 | -$28.53K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | -$74.87K derived: sum of 2 quarters · filed 2012-02-23 | -$607.38K 10-K · filed 2012-02-23 | |||||
| 2010-09-30 | -$46.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-23 | -$578.86K 10-Q · filed 2012-02-23 | ||||||
| 2010-06-30 | -$532.51K 10-Q · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |